Alexandria Real Estate Equities pairs a dominant life-science campus moat with near-term vacancy and supply pressure, creating a potential five-year recovery opportunity at roughly 7.1x forward FFO.
Overview
Alexandria Real Estate Equities is a specialized North American REIT that owns, operates, and develops collaborative life-science, agtech, and technology campuses. Its 36.0 million RSF operating portfolio is concentrated in innovation clusters including Greater Boston, San Francisco, San Diego, New York, Maryland/Research Triangle, and Seattle. The Megacampus platform, specialized laboratory infrastructure, long tenant relationships, and high switching costs differentiate it from conventional office landlords. In Q2 2026, revenue was $662.78 million, slightly above the $660.90 million consensus, while adjusted FFO of $1.73 per share matched estimates. A $0.43 diluted loss per share reflected $222.5 million of non-cash impairments; cash same-property NOI fell 8.6% year over year and occupancy was 86.9%, though 90.9% including executed future leases. Management set 2026 adjusted FFO guidance at $6.35–$6.45 per share, with a $6.40 midpoint. At approximately $45.51, shares trade at about 7.1x forward FFO, versus an 18.4x ten-year average and roughly 12x–14x peer averages. **The discount reflects genuine vacancy, supply, and rate risks, but also creates recovery potential.** Near-term catalysts include re-leasing, $135 million of development NOI, asset dispositions, and possible monetary easing.